Form D · Biotechnology

Bioretec Ltd

Tampere, H9 · CIK 0001532629

Offering snapshot reported Jan 3, 2013 · SEC filing

Reported sold
Yet to sell
Offering amount: $983K
Investors reported
0
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 3, 2013InitialYet to sellNo comparison0SEC filing
Oct 4, 2012InitialYet to sellNo comparison0SEC filing
Dec 13, 2011InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-189393
Offering is for 749,999 EUR. Above value is USD equivalent as of January 3, 2013.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
n/aNone

Source: Form D, filed Jan 3, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Robert William Harju Jeanty Director
Simo Hietaniemi Executive
Ari Pekka Sillanaukee Director
Jouko Hannu Timmerbacka Director
Hannu Timmerbacka Director
Pertti Olavi Tormala Director
Pertti Juhani Viitanen Executive
Terry Wall Director
Yrjo Erik Wichmann Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
Hermiankatu 22
Tampere, H9, 33720